TY - JOUR
T1 - Development and validation of a nomogram for early detection of malignant gallbladder lesions
AU - Written on behalf of the AME Gallbladder Cancer Collaborative Group
AU - Chen, Mingyu
AU - Cao, Jiasheng
AU - Bai, Yang
AU - Tong, Chenhao
AU - Lin, Jian
AU - Jindal, Vishal
AU - Barchi, Leandro Cardoso
AU - Nadalin, Silvio
AU - Yang, Sherry X.
AU - Pesce, Antonio
AU - Panaro, Fabrizio
AU - Ariche, Arie
AU - Kai, Keita
AU - Memeo, Riccardo
AU - Bekaii-Saab, Tanios
AU - Cai, Xiujun
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/10
Y1 - 2019/10
N2 - OBJECTIVES: Preoperative decision-making for differentiating malignant from benign lesions in the gallbladder remains challenging. We aimed to create a diagnostic nomogram to identify gallbladder cancer (GBC), especially for incidental GBC (IGBC), before surgical resection. METHODS: A total of 587 consecutive patients with pathologically confirmed gallbladder lesions from a hospital were randomly assigned to a training cohort (70%) and an internal validation cohort (30%), with 287 patients from other centers as an external validation cohort. Radiological features were developed by the least absolute shrinkage and selection operator logistic regression model. Significant radiological features and independent clinical factors, identified by multivariate analyses, were used to construct a nomogram. RESULTS: A diagnostic nomogram was established by age, CA19.9, and 6 radiological features. The values of area under the curve in the internal and external validation cohorts were up to 0.91 and 0.89, respectively. The calibration curves for probability of GBC showed optimal agreement between nomogram prediction and actual observation. Compared with previous methods, it demonstrated superior sensitivity (91.5%) and accuracy (85.1%) in the diagnosis of GBC. The accuracy using the nomogram was significantly higher in GBC groups compared with that by radiologists in the training cohort (P < 0.001) and similarly in each cohort. Notably, most of the IGBC, which were misdiagnosed as benign lesions, were successfully identified using this nomogram. DISCUSSION: A novel nomogram provides a powerful tool for detecting the presence of cancer in gallbladder masses, with an increase in accuracy and sensitivity. It demonstrates an unprecedented potential for IGBC identification.
AB - OBJECTIVES: Preoperative decision-making for differentiating malignant from benign lesions in the gallbladder remains challenging. We aimed to create a diagnostic nomogram to identify gallbladder cancer (GBC), especially for incidental GBC (IGBC), before surgical resection. METHODS: A total of 587 consecutive patients with pathologically confirmed gallbladder lesions from a hospital were randomly assigned to a training cohort (70%) and an internal validation cohort (30%), with 287 patients from other centers as an external validation cohort. Radiological features were developed by the least absolute shrinkage and selection operator logistic regression model. Significant radiological features and independent clinical factors, identified by multivariate analyses, were used to construct a nomogram. RESULTS: A diagnostic nomogram was established by age, CA19.9, and 6 radiological features. The values of area under the curve in the internal and external validation cohorts were up to 0.91 and 0.89, respectively. The calibration curves for probability of GBC showed optimal agreement between nomogram prediction and actual observation. Compared with previous methods, it demonstrated superior sensitivity (91.5%) and accuracy (85.1%) in the diagnosis of GBC. The accuracy using the nomogram was significantly higher in GBC groups compared with that by radiologists in the training cohort (P < 0.001) and similarly in each cohort. Notably, most of the IGBC, which were misdiagnosed as benign lesions, were successfully identified using this nomogram. DISCUSSION: A novel nomogram provides a powerful tool for detecting the presence of cancer in gallbladder masses, with an increase in accuracy and sensitivity. It demonstrates an unprecedented potential for IGBC identification.
UR - http://www.scopus.com/inward/record.url?scp=85074278014&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074278014&partnerID=8YFLogxK
U2 - 10.14309/ctg.0000000000000098
DO - 10.14309/ctg.0000000000000098
M3 - Article
C2 - 31663905
AN - SCOPUS:85074278014
SN - 2155-384X
VL - 10
JO - Clinical and Translational Gastroenterology
JF - Clinical and Translational Gastroenterology
IS - 10
M1 - e00098
ER -